High-Quality Palbociclib CAS 571190-30-2 | Premium Antineoplastic Agent
ProcurenetShort description
High-Quality Palbociclib CAS 571190-30-2 is a robust, pharmaceutical-grade cancer treatment drug. Sourced from Hangzhou, China, it is acknowledged globally. This product functions by inhibiting specific enzymes, effectively slowing cancer growth. Key pointers include:
- Grade: Pharmaceutical
- Molecular Weight: 447.53 g/mol
- Density: 1.313
- Boiling Point: 711.5°C at 760 mmHg
- Melting Point: 200°C
- Chemical Formula: C24H29N7O2
Storage calls for cool, dry conditions. Handle with care, using protective gear. In case of accidental exposure, seek immediate medical intervention.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
Antineoplastic Agent – Palbociclib
Belonging to the directory of key medicinal drugs, Palbociclib (CAS Number 571190-30-2) has revolutionized cancer treatment on the global stage. Belonging to the esteemed group of antineoplastic agents, Palbociclib is an innovative and high-quality compound known for its efficacy in specifically inhibiting cyclin-dependent kinase (CDK) 4 and 6 in cells. Designed to stop the progression of cancer on a cellular level, its significant role in targeted cancer therapy has led to its high demand in the pharmaceutical industry.
Chemical Properties and Descriptive Data
With a molecular weight of 447.53, Palbociclib stands out not only for its significant role in medical applications but also for its defining physical and chemical characteristics. It assumes a solid state at standard room temperature, displaying a high melting point of 200°C. This quality implies that Palbociclib is notably stable, able to withstand elevated temperatures without disintegration, a crucial requirement in multiple pharmaceutical processes. Moreover, it exhibits a high boiling point of 711.5°C under a standard atmospheric pressure (760 mmHg), further supporting its high thermal stability.
- Compound Name: Palbociclib
- CAS Number: 571190-30-2
- Molecular Weight: 447.53
- Density: 1.313
- Boiling Point: 711.5°C at 760 mmHg
- Melting Point: 200°C
- Flash Point: 384.1°C
- Refractive Index: 1.647
The designated flash point of 384.1°C and a specific density of 1.313 contribute to defining safe parameters for its handling and storage. Furthermore, the compound's refractive index stands at 1.647, augmenting its unique chemical portfolio.
Pharmaceutical Application
Palbociclib boasts of a predominant position in the treatment of cancer. Specifically, it is utilized to manage hormone receptor-positive (HR+) and human epidermal growth factor receptor 2 negative (HER2-) metastatic breast cancer in patients. Its application as a salient treatment regimen – both as a monotherapy and in combination with other cancer treatments – demonstrates considerable effectiveness, thus validating its value in modern medical therapy.
